Annual Total Liabilities
$59.66 M
-$6.16 M-9.36%
September 30, 2024
Summary
- As of February 7, 2025, SRDX annual total liabilities is $59.66 million, with the most recent change of -$6.16 million (-9.36%) on September 30, 2024.
- During the last 3 years, SRDX annual total liabilities has risen by +$5.16 million (+9.46%).
- SRDX annual total liabilities is now -9.36% below its all-time high of $65.82 million, reached on September 30, 2023.
Performance
SRDX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$51.97 M
-$7.69 M-12.90%
December 31, 2024
Summary
- As of February 7, 2025, SRDX quarterly total liabilities is $51.97 million, with the most recent change of -$7.69 million (-12.90%) on December 31, 2024.
- Over the past year, SRDX quarterly total liabilities has dropped by -$6.12 million (-10.53%).
- SRDX quarterly total liabilities is now -32.05% below its all-time high of $76.49 million, reached on June 30, 2023.
Performance
SRDX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SRDX Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -9.4% | -10.5% |
3 y3 years | +9.5% | -10.5% |
5 y5 years | +59.8% | -10.5% |
SRDX Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -9.4% | +19.4% | -32.0% | +7.8% |
5 y | 5-year | -9.4% | +59.8% | -32.0% | +72.4% |
alltime | all time | -9.4% | +3629.1% | -32.0% | +4624.6% |
Surmodics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $51.97 M(-12.9%) |
Sep 2024 | $59.66 M(-9.4%) | $59.66 M(+0.7%) |
Jun 2024 | - | $59.27 M(+0.7%) |
Mar 2024 | - | $58.85 M(+1.3%) |
Dec 2023 | - | $58.09 M(-11.7%) |
Sep 2023 | $65.82 M(+31.7%) | $65.82 M(-13.9%) |
Jun 2023 | - | $76.49 M(+20.2%) |
Mar 2023 | - | $63.61 M(+1.8%) |
Dec 2022 | - | $62.49 M(+25.1%) |
Sep 2022 | $49.97 M(-8.3%) | $49.97 M(-1.1%) |
Jun 2022 | - | $50.54 M(-0.8%) |
Mar 2022 | - | $50.92 M(+5.7%) |
Dec 2021 | - | $48.20 M(-11.6%) |
Sep 2021 | $54.51 M(+44.6%) | $54.51 M(+49.9%) |
Jun 2021 | - | $36.37 M(+3.9%) |
Mar 2021 | - | $35.01 M(+16.1%) |
Dec 2020 | - | $30.15 M(-20.0%) |
Sep 2020 | $37.71 M(+1.0%) | $37.71 M(+5.0%) |
Jun 2020 | - | $35.91 M(+17.4%) |
Mar 2020 | - | $30.58 M(-3.6%) |
Dec 2019 | - | $31.73 M(-15.0%) |
Sep 2019 | $37.35 M(-32.7%) | $37.35 M(+17.8%) |
Jun 2019 | - | $31.71 M(-11.1%) |
Mar 2019 | - | $35.67 M(-3.7%) |
Dec 2018 | - | $37.04 M(-33.3%) |
Sep 2018 | $55.52 M(+121.8%) | $55.52 M(+8.4%) |
Jun 2018 | - | $51.24 M(+2.6%) |
Mar 2018 | - | $49.96 M(+108.1%) |
Dec 2017 | - | $24.01 M(-4.1%) |
Sep 2017 | $25.04 M(-3.9%) | $25.04 M(+11.1%) |
Jun 2017 | - | $22.54 M(+3.0%) |
Mar 2017 | - | $21.88 M(+2.0%) |
Dec 2016 | - | $21.44 M(-17.7%) |
Sep 2016 | $26.06 M(+281.2%) | $26.06 M(+8.1%) |
Jun 2016 | - | $24.11 M(+1.9%) |
Mar 2016 | - | $23.65 M(+39.6%) |
Dec 2015 | - | $16.94 M(+147.8%) |
Sep 2015 | $6.84 M(+11.4%) | $6.84 M(+9.2%) |
Jun 2015 | - | $6.26 M(+13.6%) |
Mar 2015 | - | $5.51 M(+0.7%) |
Dec 2014 | - | $5.47 M(-10.8%) |
Sep 2014 | $6.14 M(-24.3%) | $6.14 M(+1.5%) |
Jun 2014 | - | $6.05 M(+19.7%) |
Mar 2014 | - | $5.05 M(-17.3%) |
Dec 2013 | - | $6.11 M(-24.6%) |
Sep 2013 | $8.11 M(-13.1%) | $8.11 M(+37.7%) |
Jun 2013 | - | $5.89 M(+5.0%) |
Mar 2013 | - | $5.61 M(-38.5%) |
Dec 2012 | - | $9.11 M(-2.3%) |
Sep 2012 | $9.33 M(-45.7%) | $9.33 M(+16.3%) |
Jun 2012 | - | $8.02 M(-5.3%) |
Mar 2012 | - | $8.47 M(-6.3%) |
Dec 2011 | - | $9.05 M(-47.3%) |
Sep 2011 | $17.17 M | $17.17 M(+10.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $15.57 M(-15.7%) |
Mar 2011 | - | $18.47 M(+5.1%) |
Dec 2010 | - | $17.57 M(+10.3%) |
Sep 2010 | $15.92 M(+20.7%) | $15.92 M(-1.9%) |
Jun 2010 | - | $16.24 M(+1.9%) |
Mar 2010 | - | $15.93 M(+4.0%) |
Dec 2009 | - | $15.32 M(+16.1%) |
Sep 2009 | $13.19 M(-73.2%) | $13.19 M(-7.0%) |
Jun 2009 | - | $14.19 M(-28.9%) |
Mar 2009 | - | $19.94 M(-12.3%) |
Dec 2008 | - | $22.73 M(-53.8%) |
Sep 2008 | $49.22 M(+21.8%) | $49.22 M(-1.2%) |
Jun 2008 | - | $49.81 M(+19.3%) |
Mar 2008 | - | $41.77 M(+14.3%) |
Dec 2007 | - | $36.53 M(-9.6%) |
Sep 2007 | $40.41 M(+231.2%) | $40.41 M(+48.0%) |
Jun 2007 | - | $27.31 M(+212.7%) |
Mar 2007 | - | $8.73 M(-34.9%) |
Dec 2006 | - | $13.41 M(+9.9%) |
Sep 2006 | $12.20 M(+41.1%) | $12.20 M(+48.9%) |
Jun 2006 | - | $8.20 M(-9.5%) |
Mar 2006 | - | $9.06 M(+25.6%) |
Dec 2005 | - | $7.21 M(-16.6%) |
Sep 2005 | $8.64 M(-43.4%) | $8.64 M(-1.9%) |
Jun 2005 | - | $8.81 M(-45.2%) |
Mar 2005 | - | $16.09 M(+55.7%) |
Dec 2004 | - | $10.34 M(-32.3%) |
Sep 2004 | $15.28 M(+30.6%) | $15.28 M(+149.7%) |
Jun 2004 | - | $6.12 M(-4.9%) |
Mar 2004 | - | $6.44 M(-28.2%) |
Dec 2003 | - | $8.97 M(-23.3%) |
Sep 2003 | $11.69 M(+61.2%) | $11.69 M(-9.0%) |
Jun 2003 | - | $12.85 M(+43.4%) |
Mar 2003 | - | $8.96 M(+33.4%) |
Dec 2002 | - | $6.71 M(-7.4%) |
Sep 2002 | $7.25 M(+48.5%) | $7.25 M(+59.2%) |
Jun 2002 | - | $4.56 M(-18.1%) |
Mar 2002 | - | $5.56 M(+26.4%) |
Dec 2001 | - | $4.40 M(-9.9%) |
Sep 2001 | $4.88 M(+99.6%) | $4.88 M(+36.4%) |
Jun 2001 | - | $3.58 M(+32.4%) |
Mar 2001 | - | $2.70 M(+40.6%) |
Dec 2000 | - | $1.92 M(-21.4%) |
Sep 2000 | $2.45 M(+6.3%) | $2.45 M(+20.6%) |
Jun 2000 | - | $2.03 M(+11.4%) |
Mar 2000 | - | $1.82 M(+21.5%) |
Dec 1999 | - | $1.50 M(-34.8%) |
Sep 1999 | $2.30 M(+43.8%) | $2.30 M(+76.9%) |
Jun 1999 | - | $1.30 M(+18.2%) |
Mar 1999 | - | $1.10 M(0.0%) |
Dec 1998 | - | $1.10 M(-31.3%) |
Sep 1998 | $1.60 M | $1.60 M(+14.3%) |
Jun 1998 | - | $1.40 M(+7.7%) |
Mar 1998 | - | $1.30 M |
FAQ
- What is Surmodics annual total liabilities?
- What is the all time high annual total liabilities for Surmodics?
- What is Surmodics annual total liabilities year-on-year change?
- What is Surmodics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Surmodics?
- What is Surmodics quarterly total liabilities year-on-year change?
What is Surmodics annual total liabilities?
The current annual total liabilities of SRDX is $59.66 M
What is the all time high annual total liabilities for Surmodics?
Surmodics all-time high annual total liabilities is $65.82 M
What is Surmodics annual total liabilities year-on-year change?
Over the past year, SRDX annual total liabilities has changed by -$6.16 M (-9.36%)
What is Surmodics quarterly total liabilities?
The current quarterly total liabilities of SRDX is $51.97 M
What is the all time high quarterly total liabilities for Surmodics?
Surmodics all-time high quarterly total liabilities is $76.49 M
What is Surmodics quarterly total liabilities year-on-year change?
Over the past year, SRDX quarterly total liabilities has changed by -$6.12 M (-10.53%)